Epidemiological analysis of infectious disease in border port areas of Heilongjiang Province, 2014–2023 Authors: Song-Ting Wei, Ying-Zi Dong, Ya-Ting Shu, Jia-Qi He, Shi-Rui Gao, Yong Zhan, Yun-Feng Wang, Xin Chen, Suo-Ni Wang, Li-Jie Zhang, Ming-Jia Bao Published: 2026 ABSTRACT AbstractBackgroundHeilongjiang Province shares a 2,981-km border with the Russian Federation and runs the largest land-port network in China. The sheer volume and diversity of cross-border movement at these ports complicates infectious disease surveillance and control. Although some individual ports and pathogens have been examined separately, a province-wide integrated analysis spanning all 18 border port municipalities has been absent. This study aimed to characterise the notifiable-disease burden across those municipalities and to identify the diseases warranting priority attention.MethodsIndividual case records of notifiable infectious diseases reported between 1 January 2014 and 31 December 2023 were retrieved from China’s National Infectious Disease Reporting Information Management System. We computed constituent ratios, crude incidence rates, and disease rankings. Joinpoint regression yielded annual percent change (APC) and average annual percent change (AAPC) estimates. Seasonality was characterised by the direct average seasonal index method. Between-group differences were evaluated with χ² or Fisher’s exact tests. A two-tailed P < 0.05 was the threshold for statistical significance, and population denominators came from the Heilongjiang Provincial Statistical Yearbook.ResultsOver the decade, 64,865 statutorily notifiable cases (out of 70,244 total reported cases) were recorded, corresponding to a mean annual incidence of 220.30 per 100,000. Respiratory diseases (37.99%) and bloodborne and sexually transmitted diseases (33.68%) jointly accounted for 71.67% of the burden. The five leading diseases were pulmonary tuberculosis (23.56%), hepatitis B (15.81%), influenza (9.85%), syphilis (9.35%), and hand, foot and mouth disease (6.48%). Overall incidence was statistically stable across the period (AAPC 1.85%, 95% CI − 0.18% to 3.93%; P > 0.05), though respiratory diseases trended upward (AAPC 6.61%, P < 0.05) while enteric and zoonotic and vector-borne diseases declined significantly (P < 0.05). Monthly incidence peaked in March (seasonal index 131%) and December (128%). Males outnumbered females (male-to-female ratio 1.51:1; rising to 3.01:1 for zoonotic and vector-borne diseases). The 15–59-year age group contributed 57.54% of cases. Farmers (31.86%), homemakers and the unemployed (23.17%), and students (10.52%) were the principal occupational groups affected. The highest cumulative incidence was observed in Mishan, Suifenhe, Mohe, Muling, and Tongjiang.ConclusionsRespiratory infections should receive heightened prevention efforts in the winter–spring season, whereas bloodborne and sexually transmitted infections call for sustained, risk-focused measures throughout the year. Working-age adults—farmers and homemakers in particular—represent the primary target population. Mishan and Suifenhe warrant reinforced surveillance, and a strengthened China–Russia cross-border joint-prevention mechanism is needed.Keywords: Heilongjiang Province, Border ports, infectious diseases, Epidemiological characteristics, Cross-border surveillance Background Heilongjiang is China’s northernmost province, sharing a 2,981-km riverine boundary with the Russian Federation across 18 border municipalities. Within these municipalities, 19 Sino-Russian land ports operate—comprising 10 waterway, six highway, two railway, and one pedestrian port currently under construction—making this the largest and most varied land-port network of any Chinese province [1]. Cross-border traffic has grown in both scale and complexity as Sino-Russian economic ties have deepened [2]. The travelling population spans business personnel, migrant workers, tourists, residents engaged in petty border trade, and transit passengers from third countries. Superimposed on this heterogeneity are pronounced seasonal swings driven by climatic and river conditions, which concentrate cross-border flows into short windows and thereby amplify the risk of introducing and sustaining infectious-disease transmission [3]. Border port areas sit at the intersection of international travel and national public-health security. The Russian Far East carries endemic burdens of haemorrhagic fever with renal syndrome, tick-borne encephalitis, and brucellosis, and has documented outbreaks of HIV and tuberculosis [4, 5]. Heilongjiang itself, owing to its northern climate and ecology, has long shouldered a comparatively heavy burden of tuberculosis [6], viral hepatitis, brucellosis [7], and haemorrhagic fever with renal syndrome—layers of local risk that compound those arriving from across the border. Published work has largely concentrated on individual ports or specific pathogens [8], leaving a gap for any province-wide, multi-disease assessment. Because the 18 municipalities differ substantially in geography, climate, demography, and economic character, their disease profiles and prevention priorities likely vary in ways that a single-site or single-pathogen study cannot capture. A systematic, province-wide analysis is therefore overdue. In this study, we conducted a descriptive epidemiological analysis of notifiable infectious disease surveillance data from all 18 border municipalities of Heilongjiang Province for the decade 2014–2023. Our objectives were to characterise the overall disease profile of these areas, to pinpoint priority diseases, key populations, and high-risk periods, and to provide an evidence base for prevention and control strategies, surveillance and early-warning systems, and cross-border joint-prevention mechanisms along China’s northern frontier. Methods Data sources Notifiable infectious disease records were extracted from the National Infectious Disease Reporting Information Management System (NIDRIMS) using “date of onset” and “current residential address” as query filters. All individual case records classified as “confirmed” or “clinically diagnosed” that were reported between 1 January 2014 and 31 December 2023 in the 18 border port areas of Heilongjiang Province were retrieved. These 18 areas are: Huma County, Mohe City, and Tahe County (Daxing’anling Prefecture); Luobei County and Suibin County (Hegang City); Aihui District, Sunwu County, and Xunke County (Heihe City); Jidong County, Hulin City, and Mishan City (Jixi City); Tongjiang City and Fuyuan City (Jiamusi City); Muling City, Dongning City, and Suifenhe City (Mudanjiang City); Raohe County (Shuangyashan City); and Jiayin County (Yichun City). Annual population denominators were obtained from the Comprehensive Management System for Disease Control and Prevention, which operates on the same information platform as NIDRIMS. Coronavirus disease 2019 (COVID-19) was excluded to prevent the exceptional reporting volume of the pandemic period from distorting long-term trends. Classification of notifiable infectious diseases in China Under the Law of the People’s Republic of China on the Prevention and Treatment of Infectious Diseases (revised in 2025), 40 infectious diseases are designated as notifiable: 2 Class A, 27 Class B, and 11 Class C. Class A diseases (n = 2): plague and cholera. Class B diseases (n = 27): COVID-19, severe acute respiratory syndrome (SARS), acquired immunodeficiency syndrome (AIDS), viral hepatitis, poliomyelitis, human infection with novel influenza subtypes, measles, haemorrhagic fever with renal syndrome (HFRS), rabies, Japanese encephalitis, dengue fever, mpox, anthrax, bacillary and amoebic dysentery, pulmonary tuberculosis, typhoid and paratyphoid fever, epidemic cerebrospinal meningitis, pertussis, diphtheria, neonatal tetanus, scarlet fever, brucellosis, gonorrhoea, syphilis, leptospirosis, schistosomiasis, and malaria. SARS and pulmonary anthrax are managed under Class A prevention and control measures. Class C diseases (n = 11): influenza, mumps, rubella, acute haemorrhagic conjunctivitis, leprosy, epidemic and endemic typhus, kala-azar (visceral leishmaniasis), echinococcosis, filariasis, hand, foot and mouth disease (HFMD), and infectious diarrhoea other than cholera, bacillary and amoebic dysentery, and typhoid and paratyphoid fever. For analysis, all reported cases from the 18 border port areas during 2014–2023 were regrouped by route of transmission into six categories: (1) Enteric infectious diseases—hepatitis A, hepatitis E, unclassified hepatitis, bacillary dysentery, typhoid and paratyphoid fever, and other infectious diarrhoea; (2) Respiratory infectious diseases—SARS-CoV-2 infection, pulmonary tuberculosis, scarlet fever, measles, pertussis, meningococcal meningitis, influenza, mumps, and rubella; (3) Bloodborne and sexually transmitted diseases—hepatitis B, hepatitis C, hepatitis D, syphilis, gonorrhoea, AIDS, HIV infection, condyloma acuminatum, genital Chlamydia trachomatis infection, non-gonococcal urethritis, and genital herpes; (4) Zoonotic and vector-borne diseases—brucellosis, HFRS, anthrax, malaria, dengue fever, amoebic dysentery, leptospirosis, typhus, echinococcosis, leishmaniasis, tick-borne encephalitis, clonorchiasis, severe fever with thrombocytopenia syndrome, and scrub typhus; (5) Contact-transmitted diseases—hand, foot and mouth disease, acute haemorrhagic conjunctivitis, and varicella (chickenpox); (6) Other diseases—acute flaccid paralysis, tuberculous pleurisy, and other unspecified notifiable infectious diseases. Statistical analysis Annual notifiable disease counts from 2014 to 2023 were compiled in Microsoft Excel and analysed by time period and population characteristics. Constituent ratios, crude incidence rates per 100,000 population, and disease rankings were computed. Monthly incidence seasonality was assessed using the direct average seasonal index method. Temporal trends were examined by joinpoint regression (Joinpoint Regression Program, version 5.2.0; National Cancer Institute, Bethesda, MD, USA), with calendar year as the independent variable and annual incidence as the dependent variable; APC and AAPC were estimated with 95% confidence intervals. All statistical analyses were performed in R version 4.3.2 (R Foundation for Statistical Computing, Vienna, Austria). Differences in rates and proportions were assessed with χ² or Fisher’s exact tests as appropriate. A two-tailed P < 0.05 was the threshold for statistical significance. Results Overall morbidity profile Between 2014 and 2023, a total of 70,244 infectious disease cases were reported across the 18 border port municipalities of Heilongjiang Province. Of these, 64,865 cases fell under 26 statutorily notifiable infectious diseases—17 Class B diseases accounting for 48,494 cases and 9 Class C diseases accounting for 16,371 cases—yielding an average annual incidence of 220.30 per 100,000. The remaining 5,379 cases (18.27 per 100,000) were attributable to other reportable but non-Class-A/B/C infectious diseases. No Class A cases were recorded throughout the decade. HIV infections and AIDS cases were reported jointly under the AIDS category. Distribution by route of transmission When all 70,244 reported cases were classified by transmission route, respiratory diseases were the largest contributor (26,686 cases, 37.99%; mean annual incidence 90.63 per 100,000), followed by bloodborne and sexually transmitted diseases (23,658 cases, 33.68%; 80.35 per 100,000), contact-transmitted diseases (8,561 cases, 12.18%; 29.08 per 100,000), zoonotic and vector-borne diseases (6,119 cases, 8.71%; 20.78 per 100,000), enteric infectious diseases (4,810 cases, 6.85%; 16.34 per 100,000), and diseases of other routes (410 cases, 0.58%; 1.39 per 100,000). Respiratory and bloodborne and sexually transmitted diseases together accounted for 71.67% of the total burden. The disease spectrum within each transmission category was highly concentrated. Pulmonary tuberculosis (62.03%) and influenza (25.93%) dominated the respiratory category; hepatitis B (46.95%) and syphilis (27.75%) the bloodborne and sexually transmitted category; HFMD (53.15%) and varicella (46.57%) the contact-transmitted category; brucellosis (63.18%) and HFRS (33.39%) the zoonotic and vector-borne category; and other infectious diarrhoea (71.91%) the enteric category. The “other routes” category comprised primarily tuberculous pleurisy (75.37%), unspecified cases (17.80%), and acute flaccid paralysis (6.83%)—most of which lie outside the standard statutorily notifiable Class A–C list. Ranking of reported infectious diseases The ten most frequently reported infectious diseases over 2014–2023 were, in descending order: pulmonary tuberculosis (16,552 cases, 23.56%), hepatitis B (11,107 cases, 15.81%), influenza (6,921 cases, 9.85%), syphilis (6,566 cases, 9.35%), HFMD (4,550 cases, 6.48%), varicella (3,987 cases, 5.68%), brucellosis (3,866 cases, 5.50%), other infectious diarrhoea (3,459 cases, 4.92%), hepatitis C (3,079 cases, 4.38%), and HFRS (2,043 cases, 2.91%). The annual rankings shifted considerably across the decade. Pulmonary tuberculosis held first place from 2014 to 2022; hepatitis B ranked second throughout most of this interval; and syphilis was most often third. Influenza first broke into the top three in 2020, coinciding with disruptions associated with COVID-19. In 2023, influenza surged to first place (214.94 per 100,000), pulmonary tuberculosis fell to second, and hepatitis B held third—reflecting the sharp rebound in respiratory infections once pandemic-era control measures were relaxed (Fig. 1). Annual rankings of the top ten reported infectious diseases in the 18 border port areas of Heilongjiang Province, 2014–2023 Epidemiological characteristics Temporal distribution Long-term trend Overall reported incidence showed no significant net change across the decade (AAPC 1.85%, P > 0.05), but joinpoint regression distinguished three sequential phases: a period of stability from 2014 to 2018 (APC 1.29%), a sharp decline from 2018 to 2021 (APC − 23.23%, P < 0.05), and a pronounced rebound from 2021 to 2023 (APC 57.37%, P < 0.05). The two inflection points coincided, respectively, with the onset and the easing of the COVID-19 pandemic, and similar V- or U-shaped trajectories were evident across most transmission categories. Trends diverged markedly by route. Respiratory diseases were the only category to show a significant net increase over the decade (AAPC 6.61%, P < 0.05), driven by a 105.81% rebound during 2021–2023. Bloodborne and sexually transmitted diseases (AAPC − 1.62%) and contact-transmitted diseases (AAPC 1.09%) showed no significant net trend but displayed pronounced phase-specific fluctuations, including a 102.47% rebound in contact-transmitted diseases during 2021–2023. Statistically significant net decreases were observed for diseases of other transmission routes (AAPC − 20.76%, P < 0.05), enteric diseases (AAPC − 12.96%, P < 0.05), and zoonotic and vector-borne diseases (AAPC − 6.08%, P < 0.05) (Fig. 2). Temporal trends in the incidence of reported infectious diseases in the border port areas of Heilongjiang Province, 2014–2023. * P < 0.05 Seasonal distribution Overall reported incidence followed a bimodal seasonal pattern, with peaks in March and December; however, the seasonality underlying this aggregate differed substantially by transmission route. Respiratory diseases drove the March and December peaks and exhibited the sharpest fluctuations of any category. Contact-transmitted diseases showed the opposite pattern, remaining low from January through May and rising through July–October. Zoonotic and vector-borne diseases displayed peaks in May–June and November, while enteric diseases peaked in summer. Bloodborne and sexually transmitted diseases and diseases of other transmission modes fluctuated only modestly. Within the respiratory category, three distinct seasonal profiles emerged. Influenza showed the most pronounced seasonality—two sharp peaks in March and December separated by an extended low-incidence window from May through October. Scarlet fever had a bimodal pattern, with a smaller spring peak in May–June and a larger one from November to December (annual maximum in December, minimum in February). Mumps peaked in the late-spring to early-summer window of April–June. Pulmonary tuberculosis remained comparatively stable throughout the year, showing only a modest elevation in the first half. These patterns together reflect a winter–spring concentration of acute respiratory transmission alongside year-round tuberculosis activity. Bloodborne and sexually transmitted diseases showed a pronounced March peak (driven mainly by hepatitis C and hepatitis B), a secondary mid-summer rise, and a modest year-end increase for gonorrhoea, against a low point in February. Hepatitis B peaked in March with smaller elevations in January and July, while hepatitis C showed its most pronounced peak of all four diseases in March followed by a deep trough from September to November. Syphilis also peaked in March with a secondary peak in August. Gonorrhoea exhibited a bimodal pattern, peaking in July and again in November–December. Despite these within-year fluctuations, the decade-long trend in bloodborne and sexually transmitted diseases remained stable. Contact-transmitted diseases divided into two complementary seasonal patterns. HFMD remained near zero from January through April, rose sharply from May and peaked in July–September, then declined rapidly. Varicella, by contrast, showed a bimodal school-calendar pattern: a smaller spring peak in June and a larger late-autumn to winter peak from October to December (highest in December), with its lowest values in August during the summer holiday. Enteric diseases also split into contrasting patterns: bacterial dysentery peaked sharply in July while other infectious diarrhoea peaked during the cold months from January to April. Hepatitis A showed a broad spring–summer plateau with an August peak; hepatitis E had three modest peaks in January, April, and December (Fig. 3). Monthly seasonal indices of reported infectious diseases by route of transmission in the border port areas of Heilongjiang Province, 2014–2023. Note: Only the major diseases within each transmission category are shown Population distribution Sex distribution During 2014–2023, 42,305 male cases (60.23%) and 27,939 female cases (39.77%) were reported across the 18 border port areas, giving a male-to-female ratio of 1.51:1. The average annual incidence was 283.17 per 100,000 in males and 190.46 per 100,000 in females (χ² = 2687.87, P < 0.001), with males exceeding females across every age group. Children aged 0–14 years consistently showed the highest incidence—typically two to four times that of the 15–59 and ≥ 60 age groups—while the 15–59 age group had the lowest. Temporal trends were broadly parallel between the sexes: incidence in children aged 0–14 years rose to a peak in 2018, fell sharply in 2020–2022, and rebounded markedly in 2023 (Fig. 4). Incidences of reported infectious disease by sex and age group in border port areas of Heilongjiang Province, 2014–2023 In sex-stratified analyses by route of transmission, males had significantly higher incidence than females in all six categories. Respective male versus female rates were: 111.62 vs. 69.24 per 100,000 for respiratory diseases (χ² = 1459.43, P < 0.001), 88.94 vs. 71.59 for bloodborne and sexually transmitted diseases (χ² = 275.70, P < 0.001), 32.37 vs. 25.72 for contact-transmitted diseases (χ² = 111.63, P < 0.001), 30.90 vs. 10.47 for zoonotic and vector-borne diseases (χ² = 1478.12, P < 0.001), 18.97 vs. 13.66 for enteric diseases (χ² = 126.71, P < 0.001), and 1.82 vs. 0.95 for diseases of other routes (χ² = 39.37, P < 0.001). The largest relative sex difference—roughly 3:1—was seen for zoonotic and vector-borne diseases (Fig. 5). Incidences of reported infectious diseases by sex and route of transmission in border port areas of Heilongjiang Province, 2014–2023 Age distribution The 15–59 age group contributed the largest number of reported cases (40,420 cases, 57.54%), followed by the 0–14 group (15,691 cases, 22.34%) and the ≥ 60 group (14,133 cases, 20.12%). When assessed by incidence rate, however, the 0–14 group ranked highest (489.53 per 100,000)—approximately 2.5 times that of the 15–59 group (194.91 per 100,000)—with the ≥ 60 group intermediate (249.46 per 100,000). Statistically significant sex differences were observed within each age group: male-to-female ratios were 1.27 (0–14 years; χ² = 28.33, P < 0.001), 1.56 (15–59 years; χ² = 1939.96, P < 0.001), and 1.53 (≥ 60 years; χ² = 630.49, P < 0.001). Occupational distribution Farmers (22,381 cases, 31.86%), homemakers and the unemployed (16,276 cases, 23.17%), and students (7,392 cases, 10.52%) were the three leading occupational groups, together contributing 65.56% of all reported cases; occupational composition differed significantly across years (χ² = 3573.977, P < 0.001) (Fig. 6a). These three groups also led in the respiratory category (farmers, 8,473 cases, 31.75%; homemakers/unemployed, 7,028 cases, 26.34%; students, 3,395 cases, 12.72%). Bloodborne and sexually transmitted diseases predominantly affected farmers (8,499 cases, 35.92%) and homemakers/unemployed individuals (7,781 cases, 32.89%). Contact-transmitted diseases were concentrated among students (3,472 cases, 40.56%), scattered children (2,158 cases, 25.21%), and nursery children (2,116 cases, 24.72%). Zoonotic and vector-borne diseases disproportionately affected farmers (4,499 cases, 73.53%), and enteric diseases mainly affected scattered children (2,799 cases, 58.19%) (Fig. 6b). A Distribution of reported infectious disease cases by occupations and years in the border port areas of Heilongjiang Province, 2014–2023. B Distribution of reported infectious disease cases by occupations and transmission routes in the border port areas of Heilongjiang Province, 2014–2023 Regional distribution By absolute case count, the five highest-burden municipalities were Mishan (14,427 cases, 20.54%), Muling (6,671 cases, 9.50%), Aihui (5,271 cases, 7.50%), Jidong (5,109 cases, 7.27%), and Hulin (5,104 cases, 7.27%), together contributing 52.08% of all reported cases. Ranked by cumulative incidence rate, the top five were Mishan (380.65 per 100,000), Suifenhe (303.33 per 100,000), Mohe (269.97 per 100,000), Muling (258.63 per 100,000), and Tongjiang (252.49 per 100,000)—with Mishan and Muling appearing in both rankings, while Suifenhe, Mohe, and Tongjiang ranked highly by incidence despite smaller populations. The geographical pattern varied by transmission route: zoonotic and vector-borne diseases concentrated in Sunwu and Xunke; bloodborne and sexually transmitted diseases in Mishan and Aihui; contact-transmitted diseases in Mohe and Suifenhe. Most municipalities showed a uniform decline during 2020–2022 followed by a marked rebound in 2023 (Fig. 7a and b; Table 1). a Geographical distribution of the incidence of reported infectious diseases in the border port areas of Heilongjiang Province, 2014–2023. b Geographical distribution of the incidence of reported infectious diseases by route of transmission in the border port areas of Heilongjiang Province, 2014–2023 Table 1Top five border port areas ranked by reported cases and incidence of infectious diseases, classified by route of transmission, Heilongjiang Province, 2014–2023IndicatorRankRespiratory infectious diseasesBloodborne and sexually transmitted infectious diseasesContact-transmitted infectious diseasesNatural focal and vector-borne infectious diseasesIntestinal infectious diseasesInfectious diseases transmitted through other modesAll reported infectious diseasesCases1stMishan(4,652)Mishan(7,463)Muling(942)Mishan(1,085)Suifenhe(1,374)Mishan(121)Mishan(14427)2ndMuling(3,055)Aihui(2,450)Luobei(914)Muling(832)Luobei(660)Jidong(83)Muling(6671)3rdDongning(2,387)Jidong(1,640)Aihui(868)Jidong(595)Muling(544)Aihui(27)Aihui(5271)4thHulin(2,265)Hulin(1,555)Suifenhe(773)Hulin(426)Mishan(382)Sunwu(24)Jidong(5109)5thJidong(1,905)Luobei(1,373)Mishan(724)Suibin(395)Jidong(255)Tongjiang(21)Hulin(5104)Incidence (1/100,000)1stMishan(122.74)Mishan(196.91)Mohe(65.72)Sunwu(33.36)Suifenhe(110.73)Huma(3.48)Mishan(380.65)2ndDongning (122.11)Aihui(113.31)Suifenhe(62.29)Xunke(32.84)Luobei(31.19)Jidong(3.30)Suifenhe(303.33)3rdTongjiang (119.90)Mohe(104.57)Sunwu(47.16)Muling(32.26)Muling(21.09)Mishan(3.19)Mohe(269.97)4thMuling(118.44)Raohe(87.02)Luobei(43.20)Huma(31.12)Mohe(17.88)Sunwu(2.51)Muling(258.63)5thXunke(89.29)Tahe(80.24)Huma(40.64)Mishan(28.63)Huma(13.01)Jiayin(1.62)Tongjiang(252.49) Top five border port areas ranked by reported cases and incidence of infectious diseases, classified by route of transmission, Heilongjiang Province, 2014–2023 Mishan (4,652) Mishan (7,463) Muling (942) Mishan (1,085) Suifenhe (1,374) Mishan (121) Mishan (14427) Muling (3,055) Aihui (2,450) Luobei (914) Muling (832) Luobei (660) Jidong (83) Muling (6671) Dongning (2,387) Jidong (1,640) Aihui (868) Jidong (595) Muling (544) Aihui (27) Aihui (5271) Hulin (2,265) Hulin (1,555) Suifenhe (773) Hulin (426) Mishan (382) Sunwu (24) Jidong (5109) Jidong (1,905) Luobei (1,373) Mishan (724) Suibin (395) Jidong (255) Tongjiang (21) Hulin (5104) Mishan (122.74) Mishan (196.91) Mohe (65.72) Sunwu (33.36) Suifenhe (110.73) Huma (3.48) Mishan (380.65) Aihui (113.31) Suifenhe (62.29) Xunke (32.84) Luobei (31.19) Jidong (3.30) Suifenhe (303.33) Mohe (104.57) Sunwu (47.16) Muling (32.26) Muling (21.09) Mishan (3.19) Mohe (269.97) Muling (118.44) Raohe (87.02) Luobei (43.20) Huma (31.12) Mohe (17.88) Sunwu (2.51) Muling (258.63) Xunke (89.29) Tahe (80.24) Huma (40.64) Mishan (28.63) Huma (13.01) Jiayin (1.62) Tongjiang (252.49) Discussion Overall epidemic profile and priority diseases Across the 10-year study period, 64,865 notifiable cases were reported in Heilongjiang’s 18 border port municipalities, giving an average annual incidence of 220.30 per 100,000. This is appreciably lower than the national average of 551.26 per 100,000 reported for overlapping periods [9, 10], yet the aggregate masks a distinct epidemiological signature: respiratory diseases (37.99%) and bloodborne and sexually transmitted diseases (33.68%) together made up more than 71% of the burden. The top ten diseases—pulmonary tuberculosis, hepatitis B, influenza, syphilis, HFMD, varicella, brucellosis, other infectious diarrhoea, hepatitis C, and HFRS—broadly overlap with, but also diverge from, the national spectrum, which in comparable analyses has been led by HFMD, other infectious diarrhoea, hepatitis B, tuberculosis, and influenza [10, 11]. The relative over-representation of tuberculosis (23.56%), brucellosis (5.50%), and HFRS (2.91%) in our study area reflects both the high-latitude ecology of Heilongjiang and the structural influence of the shared border with the Russian Far East. Tuberculosis was the most reported disease throughout almost the entire decade. Heilongjiang has long ranked among China’s highest-burden provinces for tuberculosis and drug-resistant tuberculosis: provincial annual incidence averaged 91.60 per 100,000 during 2008–2015, and the province recorded a primary multidrug-resistant tuberculosis (MDR-TB) rate of 13.6% and an acquired MDR-TB rate of up to 39.3% between 2007 and 2012 [6, 12]. The sustained predominance of tuberculosis in our cohort, and its higher incidence among men, farmers, and older adults, is consistent with provincial patterns [6] and with genomic-epidemiological work in rural northeastern China identifying dense social-contact transmission in farming communities [13]. Tuberculosis control in the border corridor is also closely tied to the cross-border epidemiological situation. In Buryatia (Russian Far East), Beijing-genotype Mycobacterium tuberculosis strains predominate among ethnic Russians while European non-Beijing strains are more frequent among Buryats; the hypervirulent Beijing 14717-15 cluster is also endemic in this region. In Omsk Province (West Siberia), 86.8% of MDR-TB isolates belong to the Beijing genotype, and the B0/W148 sublineage exhibits an elevated propensity for combined drug resistance [4, 14, 15]. The China–Russia border region therefore carries both a heavy MDR-TB burden and marked differences in strain distribution across populations. The resumption of cross-border trade, labour migration, and tourism between Heilongjiang and Russia’s Primorsky and Amur regions creates a structural risk for bidirectional tuberculosis and MDR-TB transmission—a concern raised explicitly under recent visa-free policies [16]. Hepatitis B and hepatitis C together contributed 20.19% of reported cases, reflecting the historically high chronic hepatitis B burden in northeastern China. Earlier seroepidemiological studies documented HBsAg prevalence above the national mean in Heilongjiang [17], and inpatient surveys in adjacent Jilin reported HBsAg positivity of 7.43% [18]. Nationwide joinpoint analyses indicate that hepatitis B incidence declined in the Northeast region as a whole from 2004 to 2020 (AAPC − 4.09%) [19]. Our finding that bloodborne and sexually transmitted diseases formed the second-largest category without showing a significant increasing trend is consistent with the maturing universal infant hepatitis B vaccination programme, improved blood-product screening, and the National Viral Hepatitis Prevention and Control Plan (2017–2020) [19, 20]. The continuing prominence of hepatitis C, however, suggests that adult risk groups engaged in commercial and labour mobility at the border remain inadequately reached by screening and antiviral therapy. Syphilis (9.35%) ranked fourth and serves as a useful indicator of bloodborne and sexually transmitted risk at ports of entry. Nationally, syphilis incidence has risen steadily in recent decades, with rural-to-urban migration, cross-border sex work, and sexual networks among highly mobile young men identified as key drivers [21, 22]. Port-based surveillance at Shanghai Port identified 918 syphilis cases among entry–exit personnel during 2014–2022, more than half originating from East Asia [23], and imported bloodborne and sexually transmitted infections from Russia and Mongolia have been flagged as an elevated risk at Inner Mongolia ports [8]. Our border sites receive substantial flows of Russian Far East truck drivers, shuttle traders, and tourists from a region where HIV prevalence is rising [24, 25] and likely face comparable importation pressures. Closer integration of port health quarantine with the provincial STI control system is therefore warranted. The stable local trend in bloodborne and sexually transmitted infections contrasts with rising trends reported elsewhere—a divergence plausibly reflecting both a mature prevention infrastructure (universal infant hepatitis B vaccination, mandatory nucleic-acid screening of blood donations, and the National Syphilis Prevention and Control Plan) and incomplete capture of mobile cross-border populations in routine surveillance. Sexually transmitted infections are not driven by climate, and apparent monthly fluctuations reflect testing cycles and care-seeking behaviour rather than pathogen seasonality; continuous, risk-based, year-round prevention is therefore more appropriate than seasonally targeted campaigns. Zoonotic and vector-borne diseases formed the third major cluster. Heilongjiang has historically been one of China’s three leading provinces for human brucellosis [26–28], and national incidence rose from 3.4 per 100,000 in 2016 to 5.0 per 100,000 in 2021 [28, 29], driven primarily by expansion of sheep and goat husbandry, backyard farming, and occupational exposure to parturient animals [30]. Our findings—a male-to-female ratio of 3.01:1 in zoonotic and vector-borne cases and the preponderance of farmers—are consistent with provincial studies in Qiqihar (mean annual incidence 29.50 per 100,000 during 2004–2019, 11 times the national rate, dominated by middle-aged male farmers) [31] and with hospital-based case series from Harbin Medical University, in which 74.5% of 850 brucellosis patients were male and 51.4% were farmers or herdsmen [7]. The March–July seasonal peak mirrors the national lambing-associated transmission pattern [27, 28, 32]. HFRS accounted for 2.91% of cases, confirming Heilongjiang’s status as a core hantavirus endemic focus. The province reported 10,820 HFRS cases during 2014–2023, second only to Shaanxi, and together with four other provinces contributed over half of the national HFRS burden [33]. Consistent with national surveillance and earlier provincial studies, we observed bimodal seasonality (May–June and October–December), male predominance, and geographical concentration in rural farming counties. Both Hantaan virus and Seoul virus circulate in Heilongjiang, and port-city rodent surveillance has identified Apodemus agrarius and Rattus norvegicus as the principal reservoirs, with landscape factors such as cropland extent and humidity strongly modulating incidence [33–35]. HFMD (6.48%) and varicella (5.68%)—both contact-transmitted childhood diseases—accounted for most cases in the 0–14 age group. National meta-analyses consistently rank Northeast China as the lowest HFMD-incidence region (0.54‰ versus 3.48‰ in South China), with a single annual peak typically in April–July rather than the bimodal pattern of warmer regions [36, 37]. Varicella in northern Chinese cities likewise shows two seasonal peaks tied to the school calendar [38, 39]. The substantial burden of these vaccine-preventable infections argues for continued strengthening of school-based surveillance, two-dose varicella vaccination, and EV-A71 immunisation in border port areas. Cross-border epidemiology: comparisons with the Russian Far East and other border corridors The pattern we observed reflects the specific epidemiological context of the China–Russia frontier. The Far Eastern Federal District has been described as one of Russia’s most unfavourable regions for tuberculosis, with the highest rates of primary MDR-TB, substantial TB/HIV co-infection, and limited progress relative to European Russia [4, 14, 40]. HIV prevalence in the Far Eastern Federal District has also risen sharply, with incidence continuing to climb while other Russian districts stabilise; the predominant IDU-A subtype A variant is now joined by sexually transmitted B-subtype clusters typical of maritime ports [24, 25]. Forest encephalitis, caused predominantly by the Far-Eastern subtype of tick-borne encephalitis virus and sharing natural foci with Heilongjiang, illustrates the shared ecology: about 99% of Chinese forest encephalitis cases are reported from the forested northeastern provinces, and serological positivity among tick-bitten residents of Heilongjiang remained measurable during 2020–2023 [3, 41]. Although FE did not enter our top-ten list, its persistence as a notifiable zoonosis argues for integrated zoonotic surveillance across the border. Compared with other Chinese border corridors, our findings show both commonalities and distinctive features. In the China–Myanmar border area of Yunnan, the imported disease spectrum is dominated by malaria and dengue fever reflecting the tropical ecology of the Greater Mekong Subregion [42, 43]. A hospital-based analysis of 5,760 notifiable infections in Yunnan during 2014–2023 showed similar structural dominance by respiratory and bloodborne/STI diseases (51.88% and 45.28%, respectively) [44], but with a different disease mix (tuberculosis, influenza, hepatitis B, HIV). Border counties of Inner Mongolia, by contrast, are foci of human brucellosis, plague, and tick-borne diseases, with imported bloodborne/STI cases also linked to Russian and Mongolian travellers [8, 45, 46]. Heilongjiang’s border ports thus occupy a distinctive intermediate niche—combining the temperate-zone respiratory and zoonotic burdens of high-latitude northern China with the bloodborne/STI importation risks that characterise active cross-border trade with Russia. This profile accords with the view that infectious disease threats at Chinese ports are increasingly diverse and that prevention must be tailored to the specific geographic, ecological, and trading context of each frontier [47]. The geographical distribution within the 18 municipalities is itself informative. Mishan, Muling, Aihui, Jidong, and Hulin had the highest absolute case counts, while Mishan, Suifenhe, Mohe, Muling, and Tongjiang had the highest incidence rates—a cluster that includes all the major road and railway ports of entry (Suifenhe, Heihe, Tongjiang, Dongning), which handle the bulk of land-based China–Russia trade and are expanding under the Belt and Road/China–Mongolia–Russia Economic Corridor framework [2, 48]. Several global health analyses have warned that Belt and Road-associated intensification of trade and migration can accelerate cross-regional spread of tuberculosis, HIV, hepatitis, brucellosis, and other zoonoses [2, 49]. Our spatial pattern is consistent with these warnings. Temporal trends, seasonality, and population distribution The overall AAPC of 1.85% was not statistically significant, indicating that total infectious disease incidence in the border ports was relatively stable over the decade. This aggregate, however, conceals important category-specific divergences: respiratory diseases rose significantly (AAPC 6.61%), while enteric, zoonotic/vector-borne, and other-route diseases all declined. The increase in respiratory disease incidence likely reflects several converging factors—improved laboratory capacity, broader use of molecular diagnostics for influenza and tuberculosis, expansion of the notifiable-disease reporting network following the 2013 Law on the Prevention and Control of Infectious Diseases [9, 50], and greater health-seeking behaviour in rural border populations as primary-care access improved under healthcare reform. The decline in enteric diseases is consistent with the cumulative effects of the National Viral Hepatitis Prevention and Control Plan, improved rural water and sanitation infrastructure, and stronger food-safety regulation in cold-climate counties. Because intestinal pathogens such as rotavirus and norovirus, are primarily transmitted through the fecal–oral route and their transmission process is highly dependent on household hygiene conditions [51, 52]. The reductions in zoonotic and vector-borne disease incidence parallel the National Brucellosis Prevention and Control Plan (2016–2020) and the expansion of the HFRS vaccine since 2007 [28, 29, 33]. Our decade-long incidence curve showed a discernible decrease between 2018 and 2021 followed by a resurgence in 2022–2023. Several explanations are plausible beyond any single event. First, between 2018 and 2020 a series of national and provincial control programmes were intensified—consolidation of tuberculosis case management under the Healthy China 2030 framework, stricter livestock slaughter and quarantine regulations under the Brucellosis Plan, and reinforced rodent control in HFRS-endemic counties. Second, reporting discipline and diagnostic quality improved through successive upgrades of the China Information System for Disease Control and Prevention; such upgrades can initially suppress apparent incidence through deduplication cleaning and subsequently raise it as sensitivity improves. Third, cross-border population movement fluctuated substantially owing to changing visa policies, customs reforms, and economic cycles, directly affecting the volume of imported infections through Suifenhe, Dongning, and Heihe [16, 48]. Fourth, ecological and climatic variability—interannual differences in temperature, humidity, and rodent abundance—generates multi-year oscillations in both HFRS and brucellosis [32, 35]. Finally, the reopening of land ports after 2022 coincided with demographic normalisation and plausibly reactivated both respiratory and STI transmission networks. Seasonality in the border ports was marked by dual peaks in March (131% of the monthly mean) and December (128%), with respiratory diseases peaking even more sharply (March 179%, December 172%). These peaks correspond to the cold-season respiratory-virus pattern characteristic of the continental climate zones of Northeast China, where a pronounced winter–spring influenza and tuberculosis-diagnostic wave is the norm [53–55]. The brucellosis peak from March to July aligns with the spring lambing season [28, 31, 32], while the bimodality of HFRS (May–June from Apodemus-driven transmission and October–December from Rattus-dominated transmission) reproduces national patterns [33, 34]. These actionable seasonal patterns support pre-peak vaccination campaigns, occupational health interventions before lambing, and intensified rodent control in late autumn. Demographically, the male-to-female ratio of 1.51:1—rising to 3.01:1 for zoonotic and vector-borne diseases—reflects the male preponderance of farming, herding, forestry, and long-distance transport occupations, all over-represented in the border economy [7, 27, 31]. The 15–59 age group’s 57.54% share of cases mirrors national patterns for the leading diseases (tuberculosis, brucellosis, hepatitis, STIs) and identifies the working-age population as the principal prevention target. Children drove contact-transmitted and enteric diseases, consistent with Chinese paediatric surveillance [38, 39]. The three leading occupational groups—farmers (31.86%), homemakers/unemployed (23.17%), and students (10.52%)—indicate that infection control in border port areas must reach rural households and schools rather than focusing narrowly on inbound travellers. Strengths and limitations To the best of our knowledge, this is the first study to characterise the infectious disease epidemiology of all 18 border-port municipalities of Heilongjiang Province across a complete decade, addressing a notable evidence gap at the China–Russia frontier. Strengths include use of complete national notifiable-disease reporting data, the decade-long analytic horizon enabling joinpoint and AAPC trend analysis, stratification across six transmission-route categories, and disaggregation by age, sex, occupation, and sub-municipality. Several limitations merit acknowledgement. First, passive notifiable-disease surveillance is susceptible to under-reporting, particularly for mild presentations, and to variation in diagnostic sensitivity across counties with heterogeneous laboratory capacity. Second, asymptomatic infections—such as latent tuberculosis and chronic hepatitis carriage—are not captured. Third, imported cases cannot be distinguished from locally acquired ones, limiting direct quantification of cross-border importation. Fourth, detailed behavioural, occupational-exposure, and molecular-epidemiological data were unavailable. Fifth, population denominators are based on registered permanent residents and therefore underestimate exposure among the substantial floating population of cross-border traders, truck drivers, and seasonal workers who are likely at higher risk. Conclusions During 2014–2023, infectious disease epidemiology in Heilongjiang’s 18 border-port municipalities was shaped by three converging forces: the temperate continental climate and forest–farm ecology of the province, its location along a high-traffic international frontier with the Russian Far East (a region with above-average burdens of tuberculosis, MDR-TB, HIV, and FE), and the steady maturation of national prevention and control programmes. Tuberculosis, hepatitis B, influenza, syphilis, and brucellosis emerged as priority targets. Respiratory diseases require continued strengthening of both diagnostic capacity and vaccination coverage, and the male, working-age, farmer-dominated risk profile argues for occupationally targeted education, distribution of personal protective equipment, and brucellosis control linked to livestock vaccination. Our findings support four policy directions: (i) establishing an integrated China–Russia bilateral infectious-disease surveillance and information-sharing mechanism for major ports of entry, with particular emphasis on tuberculosis/MDR-TB, HIV, syphilis, hepatitis, and tick-borne encephalitis; (ii) embedding port-quarantine screening within the provincial public health system, including active tuberculosis and STI screening of long-term cross-border workers and truck drivers; (iii) sustaining and expanding the National Brucellosis Prevention and Control Plan and the HFRS vaccination programme in high-incidence counties (Mishan, Suifenhe, Mohe, Muling, and Tongjiang); and (iv) investing in school-based vaccination for varicella and EV-A71, in rural sanitation, and in primary-care diagnostic capacity to sustain the observed declines in enteric and some zoonotic diseases. Intersectoral and international cooperation—consistent with the Belt and Road Health Silk Road framework [2, 49]—will be essential to maintaining infectious disease control at this strategically important frontier. Acknowledgements We are grateful to the public health professionals working in the 18 border port municipalities for their sustained commitment to frontline disease prevention and control at China’s northern gateway. We also thank all colleagues who offered constructive feedback during the preparation of this manuscript. Abbreviations Average annual percent change Acute flaccid paralysis Acquired immunodeficiency syndrome Annual percent change Bacillary dysentery Brucellosis Condyloma acuminatum Epidemic parotitis (mumps) Forest encephalitis (tick-borne encephalitis) Gonorrhoea Hepatitis A Hepatitis B Hepatitis C Hepatitis E Hand, foot and mouth disease Haemorrhagic fever with renal syndrome Human immunodeficiency virus Influenza Multidrug-resistant tuberculosis National Infectious Disease Reporting Information Management System Other infectious diarrhoea Other diseases Pulmonary tuberculosis Severe acute respiratory syndrome coronavirus 2 infection Scarlet fever Severe fever with thrombocytopenia syndrome Sexually transmitted infection Syphilis Tuberculous pleurisy Varicella Authors’ contributions ZLJ and BMJ, together with WST, conceived the study and designed the analytical framework. WST, HJQ, and SYT performed the data analysis and drafted the manuscript. DYZ, GSR, ZY, WYF, CX, and WSN were responsible for data collection and cleaning. ZLJ and BMJ critically reviewed and revised the manuscript. All authors contributed substantively to successive revisions and have read and approved the final version. Funding This work was jointly supported by the Public Health Talent Training Support Program of the National Administration of Disease Prevention and Control (01063) and the Special Public Health Personnel Training and Professional Technical Capacity Building programme. Data availability The datasets used and analysed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate Ethical approval was not required for this study, as the analysis used aggregated, de-identified notifiable infectious disease surveillance data obtained from the Notifiable Infectious Disease Reporting Information System (NIDRIS) of the China Information System for Disease Control and Prevention (CISDCP). No individual identifying information was accessed or reported, and no human participants were directly involved. All methods were conducted in accordance with the relevant guidelines and regulations. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Song-Ting Wei, Ying-Zi Dong and Ya-Ting Shu contributed equally to this work and share first authorship. Contributor Information Li-Jie Zhang, Email: zhanglj@chinacdc.cn. Ming-Jia Bao, Email: cmubmj@163.com. References Associated Data Data Availability Statement The datasets used and analysed during the current study are available from the corresponding author on reasonable request.